Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

AstraZeneca Receives Complete Response Letter from FDA for ZS-9 for Hyperkalaemia

americanpharmaceuticalreviewMarch 20, 2017

Tag: FDA , hyperkalaemia

PharmaSources Customer Service